A 65‐year‐old Japanese woman with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma, a rare type with a poor prognosis, is presented. Oral bexarotene and vorinostat were ineffective, and hematopoietic stem cell transplantation was scheduled. We stress that primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma should be treated with bone marrow transplantation when available.
No takes yet. Share an insight, caveat, or question.
Shimizu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: